ERDOĞAN, S. Et Al. 2023. Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?. Acta Neurologica Belgica , vol.123, no.6 , 2441-2444.

ERDOĞAN, S., YALÇIN ÇAKMAKLI, G., ELİBOL, B., CEYLANER, S., & AKBOSTANCI, M. C., (2023). Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?. Acta Neurologica Belgica , vol.123, no.6, 2441-2444.

ERDOĞAN, SEYDA Et Al. "Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?," Acta Neurologica Belgica , vol.123, no.6, 2441-2444, 2023

ERDOĞAN, SEYDA Et Al. "Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?." Acta Neurologica Belgica , vol.123, no.6, pp.2441-2444, 2023

ERDOĞAN, S. Et Al. (2023) . "Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?." Acta Neurologica Belgica , vol.123, no.6, pp.2441-2444.

@article{article, author={SEYDA ERDOĞAN Et Al. }, title={Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?}, journal={Acta Neurologica Belgica}, year=2023, pages={2441-2444} }